RxDoctor Payments Data

Jenna Berezansky, PA

Medical · Lumberton, NJNPI 1447905823

Payments from drug & device makers

$3,792in general payments, 2019–2025

Across 217 payments — averaging $17.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$786
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$748
  • Takeda Pharmaceuticals U.S.A., Inc.$405
  • Johnson & Johnson$232
  • Ardelyx, Inc.$227
  • Cumberland Pharmaceuticals, Inc.$205
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$3,792100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,792 in reported general payments places this provider in the 85th percentile of 573 medical providers in New Jersey.

See all medical providers in New Jersey

Medicare billing

Part B allowed, 2024
$46,769
Medicare patients
386
Services billed
482

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide45$50,539
Dexlansoprazole DrDexlansoprazole19$8,745
Sucralfate53$5,108
Pantoprazole Sodium243$3,842
Lubiprostone44$3,832
Omeprazole224$3,501
Colestipol Hcl43$3,229
Famotidine194$2,654
Esomeprazole Magnesium45$1,490
Ondansetron OdtOndansetron48$1,412
CholestyramineCholestyramine (With Sugar)11$1,399
Dicyclomine Hcl61$1,347
Lansoprazole16$765
Hydrocortisone11$115

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$786$50,53945 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 573 medical providers in New Jersey.

Other medical in Lumberton

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →